Stocks
OnKure Therapeutics, Inc.OKUR
NASDAQHealthcareBiotechnology$2.52
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing precision oncology therapies, with a lead program targeting a specific genetic mutation in solid tumors. Its pipeline focuses on small-molecule inhibitors designed for cancers with high unmet need, and investors track it for early-stage trial data and potential partnership opportunities.
52W Range: $2.01-$5.38
Congressional Interest in OnKure Therapeutics, Inc. (OKUR)
No congressional trades have been disclosed for OnKure Therapeutics, Inc. (OKUR) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading OKUR?
No congressional trades found for this stock.